ALISON HODGES: Open Payments
NPI 1790064046 · MAITLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$996 in 52 payments from 11 companies in 2025. Trend: 2023 $277 · 2024 $697 · 2025 $996
Food & beverage: $992Education: $4
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $274 |
| Corium, LLC | 12 | $200 |
| ABBVIE INC. | 13 | $159 |
| Axsome Therapeutics, Inc. | 11 | $146 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Bausch Health US, LLC | 3 | $52 |
| Neurocrine BioSciences, Inc. | 1 | $38 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: CAPLYTA, Azstarys, VRAYLAR, Auvelity, REXULTI, APLENZIN, INGREZZA, Jornay PM.
Industry payments across FL — which companies pay providers there.
